There is no universal agreement on the measurements that should be used to diagnose hypertension and monitor BP in people on dialysis, even though they have their BP checked more frequently than any other group of patients. There is absence of randomised control trial (RCT) data comparing various BP monitoring techniques and their effects on long-term outcomes. However, there are emerging themes from the current research that must be incorporated into clinical practice for people receiving haemodialysis. The evidence is even more scarce in people receiving peritoneal dialysis. Therefore, recommendations made here are based on either very low-grade evidence or expert opinion.
Navigate to sections